학술논문

A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11–12 months
Document Type
Article
Source
In Vaccine 19 July 2016 34(33):3810-3816
Subject
Language
ISSN
0264-410X